MEDTRONIC PUERTO RICO OPERATIONS CO. INTERSTIM X; STIMULATOR, ELECTRICAL, IMPLANTABLE, FOR INCONTINENCE
|
Back to Search Results |
|
Model Number 97800 |
Device Problems
Failure to Deliver Energy (1211); Migration or Expulsion of Device (1395); Unintended Collision (1429); Therapy Delivered to Incorrect Body Area (1508)
|
Patient Problems
Bruise/Contusion (1754); Incontinence (1928); Undesired Nerve Stimulation (1980); Pain (1994)
|
Event Date 07/01/2023 |
Event Type
malfunction
|
Event Description
|
Information was received from a patient regarding an implantable neurostimulator for the treatment of bladder issues.It was reported that it seems like the wires have moved.Patient said the therapy is stimulating the side of their butt instead of where it's supposed to be stimulating which is their bladder.Patient also stated they started having accidents again.Patient first noticed this about 3 weeks after they had their check up with the doctor which they think was sometime in july.Patient thought it was just them so they tried to increase stimulation but it became painful.Patient also mentioned they started to fall and bumped their butt hard on the end of the door.Patient confirmed they didn't actually fall but this was the time when the issues started.Patient service specialist reviewed how to change programs and patient was able to successfully switch to a different program.Patient will maintain stimulation level and will continue to track symptoms.Confirmed stimulation in bicycle seat area and comfortable.Redirect to doctor if issue persists.
|
|
Manufacturer Narrative
|
B3: date is approximate.Year is confirmed valid.Section d references the main component of the system.Other medical products in use during the event include: brand name surescan; product id: 978b128.(lot: va2qbhb); product type: 0200-lead; implant date: (b)(6) 2023.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Manufacturer Narrative
|
Continuation of d10: product id 978b128 lot# va2qbhb implanted: (b)(6) 2023: product type lead medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Additional information was received from the patient.They reported that they had called previously regarding feeling stimulation on the side of their butt instead of their uterus.Patient stated they had made an adjustment as previously noted.Patient stated they now feel stimulation where the ins is and that they have a bruise over the ins that hurts.Caller was redirected to hcp.Patient stated hcp had directed them to medtronic, but patient will call hcp again.Patient will call back if therapy adjustment is needed.
|
|
Search Alerts/Recalls
|
|
|